Empagliflozin and left ventricular remodeling in people without diabetes: primary results of the EMPA-HEART 2 CardioLink-7 randomized clinical trial
KA Connelly, CD Mazer, P Puar, H Teoh, CH Wang… - Circulation, 2023 - Am Heart Assoc
Background: Sodium-glucose cotransporter 2 inhibitors have been demonstrated to promote
reverse cardiac remodeling in people with diabetes or heart failure. Although it has been …
reverse cardiac remodeling in people with diabetes or heart failure. Although it has been …
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial
KA Connelly, CD Mazer, P Puar, H Teoh, CH Wang… - 2023 - pubmed.ncbi.nlm.nih.gov
Background Sodium-glucose cotransporter 2 inhibitors have been demonstrated to promote
reverse cardiac remodeling in people with diabetes or heart failure. Although it has been …
reverse cardiac remodeling in people with diabetes or heart failure. Although it has been …
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial
KA Connelly, CD Mazer, P Puar, H Teoh, CH Wang… - Circulation, 2023 - pure.lib.cgu.edu.tw
Background: Sodium-glucose cotransporter 2 inhibitors have been demonstrated to promote
reverse cardiac remodeling in people with diabetes or heart failure. Although it has been …
reverse cardiac remodeling in people with diabetes or heart failure. Although it has been …
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial.
KA Connelly, CD Mazer, P Puar, H Teoh, CH Wang… - Circulation, 2022 - europepmc.org
Background: Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been demonstrated
to promote reverse cardiac remodeling in people with diabetes or heart failure. While it has …
to promote reverse cardiac remodeling in people with diabetes or heart failure. While it has …
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial
KA Connelly, CD Mazer, P Puar, H Teoh, CH Wang… - Circulation, 2023 - pure.lib.cgu.edu.tw
Background: Sodium-glucose cotransporter 2 inhibitors have been demonstrated to promote
reverse cardiac remodeling in people with diabetes or heart failure. Although it has been …
reverse cardiac remodeling in people with diabetes or heart failure. Although it has been …